Abstract
Background.
This study evaluated the inhibitory activity of somatostatin 14 on the angiogenesis of cornea in vivo.
Methods.
Corneal neovascularization was induced with a pellet containing 90 ng of basic fibroblast growth factor (bFGF) in a rat corneal pocket model. Three kinds of pellets were made containing bFGF plus somatostatin (SST) 0 ng, 20 ng and 200 ng for the control group, group 1 and group 2, respectively. Neovascularization was observed biomicroscopically from day 4 to day 8, and the corneas were then examined for changes in histology. Quantitation of angiogenesis in the cornea was accomplished by caliper and image analysis.
Results.
The 200-ng dose of SST showed significant inhibition of both length and area of neovascularization on day 7 (0.62±0.11 mm vs 1.29±0.16 mm, 0.50±0.16 mm2 vs 1.35±0.29mm2, group 2 vs control; P <0.05). The 20 ng of somatostatin did not demonstrate any significant inhibition of neovascularization compared with the control group.
Conclusion.
Our study demonstrated that SST 14 can reduce bFGF-induced corneal angiogenesis. This shows the potential value of somatostatin in the treatment of corneal neovascularization.
Similar content being viewed by others
References
Adamis AP, Meklir B, Joyce NC (1991) In situ injury-induced release of basic-fibroblast growth factor from corneal endothelial cells. Am J Pathol 139:961–966
Akbar M, Okajima F, Tomura H, Majid MA, Yamada Y, Seino S, Kondo Y (1994) Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS-7 cells. FEBS Lett 348:192–196
Barrie R, Woltering EA, Hajarizadeh H, Mueller C, Ure T. Fletcher WS (1993) Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 55:446–450
Bell GI, Reisine T (1993) Molecular biology of somatostatin receptors. Trends Neurosci 16:34–38
Benelli U, Bocci G,. Danesi R, Lepri A, Bernardini N, Bianchi F, Lupetti M, Dolfi A, Campagni A, Agen C, Nardi M, Del Tacca M (1998) The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp Eye Res 67:133–142
Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M (1999) Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 43:205–212
Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV (1994) Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci U S A 91:2315–2319
D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 91:4082–4085
Danesi R, Agen C, Benelli U, Paolo AD, Nardini D, Bocci G, Basolo F, Campagni A, Tacca MD (1997) Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201–995). Clin Cancer Res 3:265-272
Florio T, Rim C, Hershberger RE, Loda M, Stork PJ (1994) The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 8:1289–1297
Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 90:2690–2694
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Hayashi N, Nakayasu K, Okisaka S (1996) Immunohistochemical localization of acidic and basic fibroblast growth factor through corneal neovascularization in vivo and in vitro. Nippon Ganka Gakkai Zasshi 100:587–591
Higgins RD, Yan Y, Schrier BK (2002) Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res 2002 74:553–559.
Hill JC, Maske R (1988) An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 46:26–30
Holz FG, Krastel H, Breitbart A, Schwarz-Eywill M, Pezzutto A, Volcker HE (1992) Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. Ger J Ophthalmol 1:142–144
Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37:1625–1632
Klein-Soyer C, Beretz A, Cazenave JP, Driot F, Maffrand JP (1990) Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor. Biol Cell 68:231-238
Klisovic DD, O'Dorisio MS, Katz SE, Sall JW, Balster D, O'Dorisio TM, Craig E, Lubow M (2001) Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Invest Ophthalmol Vis Sci 42:2193–2201
Lawnicka H, Stepien H, Wyczolkowska J, Kolago B, Kunert-Radek J, Komorowski J (2000) Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Biochem Biophys Res Commun 268:567–571
Li WW, Grayson G, Folkman J, D'Amore PA (1991) Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci 32:2906–2911
Liebow C, Reilly C, Serrano M, Schally AV (1989) Somatostatin analogues inhibit growth of pancreaic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci U S A 86:2003–2007
Mallet B, Vialettes B, Haroche S, Escoffier P, Gastaut P, Taubert JP, Vague P (1992) Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201–995. Diabete Metabolisme 18:438–444
Patel PC, Barrie R, Hill N, Landeck S, Kurozawa D, Woltering EA (1994) Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis. Surgery 116:1148–1152
Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157–198
Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB (1994) All five cloned human somatostatin receptors (hSSTR1–5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198:605–612
Pawlikowski M, Lachowicz L, Kunert-Radek J, Winczyk K, Janiszewska G, Szkudlarek J (1998) Differential effects of somatostatin and its analog on protein tyrosine kinases activity in the rat pituitary and the murine colonic tumors. Biochem Biophys Res Commun 246:375–377
Reubi JC, Laissue JA (1995) Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 16:110–115
Woltering EA, Watson JC, Alperin-Lea RC, Sharma C, Keenan E, Kurozawa D, Barrie R (1997) Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action. Invest New Drugs 15:77–86
Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A 89:251–255.
Yasuda K, Rens-Domiano S, Breder CD, Law SF, Saper CB, Reisine T, Bell GI (1992) Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J Biol Chem 267:20422–20428
Acknowledgements.
This work was supported by a project grant from Chang Gung Memorial Hospital Grand CMRP and National Science Council Grand NMRP. The authors thank Professor Nina Gloriani Barzaga for reading and editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
The first, second, and third authors contributed equally
No commercial relationship
Rights and permissions
About this article
Cite this article
Wu, PC., Liu, CC., Chen, Ch. et al. Inhibition of experimental angiogenesis of cornea by somatostatin. Graefe's Arch Clin Exp Ophthalmol 241, 63–69 (2003). https://doi.org/10.1007/s00417-002-0591-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-002-0591-7